Health Care

Trump Signs Executive Orders to Lower Drug Prices

President Trump has recently signed an executive order aimed at reducing the costs of prescription drugs in the United States. The order seeks to ensure that American prices align with those in wealthier nations, encouraging drug manufacturers to voluntarily lower their prices.

This directive tasks Robert F. Kennedy Jr., the head of Health and Human Services, with establishing a “clear target” for new drug pricing within the next 30 days, with hopes it might spark negotiations between pharmaceutical companies and the administration. If no talks commence, Kennedy is prepared to enforce a “most favored nation” pricing model, which would involve setting prices at least as low as those paid in comparable countries.

Moreover, the order indicates that the government will explore increasing drug imports or implementing other regulations if manufacturers don’t act quickly to adjust prices in the U.S.

Essentially, Trump expressed during a press conference, “What we’re doing is ensuring everyone pays the same.” However, the specifics of the legal authority enabling this push for lower prices weren’t clarified.

Interestingly, a 2024 RAND Corporation study highlighted that Americans pay, on average, 2.78 times more than people in 33 other wealthy nations for their medications. This discrepancy in drug pricing has persisted for years.

Although the Trump administration has previously tried to initiate similar measures, they faced legal obstacles, as a federal judge blocked these efforts in 2020.

GOP Medicaid Cuts: A Moral Dilemma?

In other significant news, GOP members are proposing substantial cuts to Medicaid. Senator Josh Hawley (R-Mo.) expressed grave concerns over these proposed reductions, describing them as “morally wrong and politically suicidal.”

In a recent op-ed, he criticized using reductions in healthcare funding for working-class citizens as a means to finance Trump’s domestic initiatives. House Republicans revealed plans that could lead to billions in savings but could also result in millions losing their health insurance.

Despite internal party discussions, the most controversial changes to Medicaid weren’t included in the proposals made known last Sunday.

Listeria Outbreak Linked to Prepared Foods

Additionally, a recent listeria outbreak traced back to prepared foods has left at least ten individuals hospitalized. Products from the Fresh & Ready Foods Company, distributed in states like California, Arizona, Nevada, and Washington, have been recalled. The FDA has resumed investigations into this ongoing health crisis.

As healthcare policies evolve and outbreaks arise, it seems the landscape of American health care remains under continuous scrutiny. The developments over the next few weeks will likely be crucial in shaping the future of both drug pricing and healthcare access in the U.S.